In the present study, we examined the associations between MED12 mutations and four aspects of uterine fibroids: (1) genome wide methylation profiles, (2) cellular functions as revealed by transcriptome analyses, (3) different histopathological features and (4) the expressions of NRG1 and SATB2. The gene discussed is NRG1; the disease is uterine corpus leiomyoma.